Drug Type Small molecule drug |
Synonyms Naproxen Sodium/Diphenhydramine Hydrochloride, Aleve Pm |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor inverse agonists(Histamine H1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (17 Jan 2014), |
Regulation- |
Molecular FormulaC14H14NaO3 |
InChIKeyCNQOEXOJUIMDHW-FVGYRXGTSA-N |
CAS Registry26159-34-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Diphenhydramine Hydrochloride/Naproxen Sodium | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sleep Initiation and Maintenance Disorders | US | 17 Jan 2014 |